Category Archives: Genetic Medicine

22-01-2012 23:39 Jan. 23 (Bloomberg) -- Dana Nieder, mother of three-year-old Maya Nieder, talks with Bloomberg's John Lauerman about her daughter's undiagnosed genetic disorder and her struggles with medical and insurance bureaucracies for advanced testing. (Source: Bloomberg)

Read the original post:
Mother Seeks Answers to Daughter's Genetic Illness - Video

18-01-2012 03:45 Tonight on the Tuesday, January 17, 2012 edition of the Infowars Nightly News: • Alex interviews Infowars contributing writer and vaccine researcher Curt Linderman Sr. about the medical tyranny hoax that ceaseless continues in trying to trick the public into complying with "mandatory" vaccinations. In the latest episode, a Pennsylvanian doctor reported her patient to a state trooper, as well as Children and Youth Services Department, after the mother, Rachel Garmon, refused dangerous inoculations for her son. Garmon appeared on the Alex Jones Show early today to explain what had prompted being contacted by the authorities following her 2 1/2 year old's check-up. Linderman wrote, in part: Suddenly, the visit took a turn for the worse as the pediatrician, classically trained in the heretical arts of poisoning young children in the name of health, began to attempt the indoctrination of vaccination into this wayward mother. Rachel however, stood her ground and explained to the doctor that she had "strong convictions against vaccinating (her) son and he was not going to get any shots." Rachel also refused to sign the self incriminating form designed by the American Academy of Pediatrics that basically states that you are a horrible parent for not protecting your child with poisonous vaccines. This is a document that no parent should sign as this can be used against you when CPS or Children and Youth Services begin to push their agenda in a family court situation. By the end of ...

Read the original here:
Medical Tyranny: Infowars Nightly News - Video

Public
release date: 29-Jan-2012
[ |
E-mail
| Share

]

Contact: Dr. Samuli Ripatti
samuli.ripatti@fimm.fi
358-206-108-159
University of Helsinki

In a study to the genetic variance of human metabolism,
researchers have identified thirty one regions of the genome
that were associated with levels of circulating metabolites,
i.e., small molecules that take part in various chemical
reactions of human body. Many of the studied metabolites are
biomarkers for cardiovascular disease or related disorders,
thus the loci uncovered may provide valuable insight into the
biological processes leading to common diseases.

Laboratory tests used in the clinic typically monitor one or
few circulating metabolites. The researchers at the Institute
for Molecular Medicine Finland (FIMM) used a high throughput
method called nuclear magnetic resonance (NMR) that can measure
more than hundred different metabolites in one assay. This
provides a much more in-depth picture of circulating metabolic
compounds.

"Using this extensive analysis in thousands of people, we could
identify a large number of genetic loci regulating the level of
compounds circulating in the blood stream", says Dr. Samuli
Ripatti, the leader of the study.

The team assayed 117 detailed metabolic markers, including
lipoprotein subclasses, amino acids and lipids, and conducted
the largest genome-wide association analysis of this type, in
terms of study sample size of 8330 individuals from six Finnish
population-based cohorts and 7.7 million genomic markers
studied. They revealed, in total, 31 genetic regions associated
with the blood levels of the metabolites.

Eleven of the loci had not been previously shown to be
associated with any metabolic measures.

Among the findings were two new loci affecting serum
cholesterol subclass measures, well-established risk markers
for cardiovascular disease, and five new loci affecting levels
of amino acids recently discovered to be potential biomarkers
for type 2 diabetes. The discovered variants have significant
effects on the metabolite levels, the effect sizes being in
general considerably larger than the known common variants for
complex disease have.

Also, using Finnish twin pair samples, the researchers
indicated that the metabolite levels show a high degree of
heritability. "This result suggests that the studied
metabolites are describing better the underlying biology than
the routinely used laboratory tests. Therefore, the study
provides further support for the use of detailed data on
multitude of metabolites in genetic studies to provide novel
biological insights and to help in elucidating the processes
leading to common diseases", Dr. Ripatti says.

###

Dr. Samuli Ripatti is a FIMM-EMBL Group Leader at the Institute
for Molecular Medicine Finland (FIMM), University of Helsinki,
Finland (http://www.fimm.fi)
and a Honorary Faculty Member at the Wellcome Trust Sanger
Institute, UK (http://www.sanger.ac.uk)

The Institute for Molecular Medicine Finland FIMM is an
international research institute focusing on building a bridge
from discovery to medical applications. FIMM investigates
molecular mechanisms of disease using genomics and medical
systems biology in order to promote human health. FIMM is a
multi-disciplinary institute combining high-quality science
with unique research cohorts and patient materials, and
state-of-the-art technologies. Website http://www.fimm.fi

The Wellcome Trust Sanger Institute is one of the world's
leading genome centres. Through its ability to conduct research
at scale, it is able to engage in bold and long-term
exploratory projects that are designed to influence and empower
medical science globally. Institute research findings,
generated through its own research programmes and through its
leading role in international consortia, are being used to
develop new diagnostics and treatments for human disease.
Website http://www.sanger.ac.uk/

[ |
E-mail
| Share

]

AAAS and EurekAlert! are not responsible for the accuracy
of news releases posted to EurekAlert! by contributing
institutions or for the use of any information through the
EurekAlert! system.

Follow this link:
Genetic regulation of metabolomic biomarkers - paths to cardiovascular diseases and type 2 diabetes

Via Scoop.it – inPharmatics

Oracle Exadata gets into Personlized Medicine & Bioinformatics space dressed as Oracle® Health Sciences Omics Data Bank.    Oracle Health Sciences today announced availability of Oracle® Health Sciences Omics Data Bank, a molecular data model, which is part of Oracle Health Sciences Translational Research Center.   The new data model provides integration and analysis of cross-platform omics data to support translational research. Oracle Health Sciences Translational Research Center runs on Oracle Exadata Database Machine, delivering the extreme performance required for querying vast data sets.
Via http://www.oracle.com

Source:
http://microarray.wordpress.com/feed/

22-12-2011 08:22 ?For several years we have employed psychophysics, electrophysiological (ERP) and magnetic resonance imaging (MRI) techniques to study the development and plasticity of the human brain.

Original post:
Experiential Genetic and Epigenetic Effects on Neurocognitive Development - Video

28-11-2011 16:55 Megan shares her story about her daughter with Phelan-McDermid syndrome. This workshop is part of a genomics curriculum for practicing healthcare providers developed by the Genomic Medicine Institute at El Camino Hospital, Genetic Alliance, and the National Coalition for Health Professional Education in Genetics. This workshop, the third in a 10-part series, covered genetic-testing technology; selecting appropriate genetic tests; ordering tests; pre- and post-test counseling; test costs; interpreting test results.

Read more from the original source:
Workshop 3: Fundamentals of Genetic Testing Part II - Megan O'Boyle - Video